GM
GT MEDICAL TECHNOLOGIES, INC.
SEC filingOther Health Care · Tempe, AZ
Amount raised$50.1Msold at filing
Total offering$100.1M$50M still open
Investors in the raise39count reported to the SEC
FiledJul 22, 2026first sale May 8, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Susana AmorimDirector
Jason RostovskyDirector
Prattipati LaxminarainExecutive Officer, Director
James LeechExecutive Officer
Per LangoeExecutive Officer, Director
Paul EneverDirector
Kyle DempseyDirector
David BrachmanExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.